İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

VİLDAN GÜRSOY

DOÇENT

BURSA ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Makale 49 YÖKSİS · 49 OpenAlex · 0
Proje 0
Kitap 6
Bildiri 59

YÖKSİS ve OpenAlex ayrı sayılır.

Alan sıralaması

YÖKSİS ?

Araştırma konuları

OpenAlex

Dizin çeyrekleri

?
Scopus (SJR) 30
  • Q1 4
  • Q2 7
  • Q3 14
  • Q4 5
WoS (JCR) 28
  • Q1 6
  • Q2 4
  • Q3 7
  • Q4 11
TR Index TR Index

17 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 1
  • Ort. 55.4%
  • n 7
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 28 Q1 2 Q2 7 Q3 14 Q4 5
  • YÖKSİS satırı 30

WoS (JCR)

  • Özet hariç 26 Q1 4 Q2 4 Q3 7 Q4 11
  • YÖKSİS satırı 28

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

37 dergi
Scopus (SJR)
Q1 4 Q2 7 Q3 14 Q4 5
WoS (JCR)
Q1 6 Q2 4 Q3 7 Q4 11
TR Index
17 makale

Makale listesi

  1. 2025 Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye Diagnostics DOI https://www.mdpi.com/2075-4418/15/5/633/pdf YÖKSİS SJR Q2 JCR Q1
  2. 2025 Dynamic ΔEASIX score is a robust predictor of survival and relapse after allogeneic hematopoietic cell transplantation in acute leukemia Blood DOI 10.1182/blood-2025-4293 YÖKSİS SJR Q1 JCR Q1
  3. 2025 Validation and interpretation of the Triple A model in Turkish myeloproliferative neoplasm patients with a focus on overall and thrombosis free survival Journal of Hematopathology DOI 10.1007/s12308-025-00668-0 YÖKSİS SJR Q3 JCR Q4 OpenAlex 38.1%
  4. 2025 Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology Journal of Thrombosis and Thrombolysis DOI 10.1007/s11239-024-03043-5 YÖKSİS SJR Q3 JCR Q4 OpenAlex 77.8%
  5. 2025 Viable and Functional: Long-Term −80 °C Cryopreservation Sustains CD34+ Integrity and Transplant Success Journal of Clinical Medicine DOI 10.3390/jcm14197032 YÖKSİS SJR Q2 JCR Q1
  6. 2025 Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy Diagnostics DOI 10.3390/diagnostics15020185 YÖKSİS SJR Q2 JCR Q1
  7. 2025 Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study Journal of Oncology Pharmacy Practice DOI 10.1177/10781552241280615 YÖKSİS SJR Q3 JCR Q4 OpenAlex 19.7%
  8. 2025 Shifting Paradigms in Antifungal Prophylaxis and Their Effects on Candidemia Outcomes in Hematological Malignancies: A 14-Year Experience from a Single Tertiary Center Journal of Fungi DOI https://pmc.ncbi.nlm.nih.gov/articles/PMC12471038/pdf/jof-11-00630.pdf YÖKSİS SJR Q1 JCR Q1
  9. 2025 Could PTH/Ca Ratio Serve as a New Marker for Evaluating Bone Metabolism in Hemophilia Patients? Diagnostics DOI 10.3390/diagnostics15050638 YÖKSİS
  10. 2025 Predictive Value of Modified Endothelial Activation and Stress Index (mEASIX) for Ruxolitinib Response inGraft-versus-Host Disease Journal of Uludağ University Medical Faculty DOI https://dergipark.org.tr/en/pub/uutfd/article/1790006 YÖKSİS TR Index
  11. 2025 Investigation of polyneuropathy in transfusion-dependent thalassemia Eastern Journal Of Medicine DOI 10.5505/ejm.2025.29626 YÖKSİS TR Index SJR Q4
  12. 2025 Immunonutritional profiling for prognostic assessment in diffuse large b-cell lymphoma: an initial evaluation of the C-reactive Protein-Albumin-Lymphocyte (CALLY) Index HEALTH SCIENCES MEDICINE DOI https://dergipark.org.tr/en/download/article-file/5180351 YÖKSİS TR Index
  13. 2024 Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia Hemoglobin DOI 10.1080/03630269.2024.2412111 YÖKSİS SJR Q3 JCR Q4
  14. 2024 A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients Leukemia & Lymphoma DOI 10.1080/10428194.2024.2395458 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.7%
  15. 2024 Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2024.2023.0430 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 91.2%
  16. 2024 Comparison of the Effectiveness of Risk Models Used in Acute Promyelocytic Leukemia UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI DOI 10.4999/uhod.247566 YÖKSİS
  17. 2024 HALP score as a novel prognostic factor for patients with myelodysplastic syndromes Scientific Reports DOI 10.1038/s41598-024-64166-6 YÖKSİS TR Index
  18. 2024 Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey Blood DOI 10.1182/blood-2024-193433 YÖKSİS SJR Q1 JCR Q1
  19. 2024 Investigation of Depression, Anxiety, Sleep Quality, and Fatigue in Thalassemia Major Patients: A Study of the Correlation Between Sleep Quality and Laboratory Findings Cureus DOI 10.7759/cureus.72614 YÖKSİS JCR Q2
  20. 2023 The Clinical Impacts of the Controlling Nutritional Status Score on Patients with Hodgkin Lymphoma EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES YÖKSİS SJR Q2 JCR Q2

Akademisyenlere dön